Arkolith/Insider Trading/ZBIO/Form 4

Nunn Jason Raleigh

DirectorZenas BioPharma, Inc. (ZBIO) · full profile →Form 4 · filed Oct 14, 2025
Net Buying
Open-Market Buys
$1.2M
Open-Market Sells
$0
Net Open-Market Flow
$1.2M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 9, 2025Buy(P)63K$19.00$1.2M1.2M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-239158) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML